Topics

As Belviq Goes Off India Market, Patent Case May Fizzle

05:24 EST 14 Feb 2020 | SCRIP

Eisai and partner Sun to take lorcaserin off the Indian market. It remains to be seen whether the Japanese firm...

      

Related Stories

 

Original Article: As Belviq Goes Off India Market, Patent Case May Fizzle

NEXT ARTICLE

More From BioPortfolio on "As Belviq Goes Off India Market, Patent Case May Fizzle"

Quick Search

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...